Thiacetazone, an Antitubercular Drug that Inhibits Cyclopropanation of Cell Wall Mycolic Acids in Mycobacteria

Anuradha Alahari, Xavier Trivelli, Yann Guérardel et al. · 2007

Read Thiacetazone, an Antitubercular Drug that Inhibits Cyclopropanation of Cell Wall Mycolic Acids in Mycobacteria by Anuradha Alahari, Xavier Trivelli, Yann Guérardel et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001343.txt.

Description

Thiacetazone is an old antitubercular drug whose precise action was unclear. Anuradha Alahari and colleagues report how it works against mycobacteria, in a 2007 PLOS ONE article. The mycobacterial cell wall is rich in mycolic acids, complex branched fatty acids that make the wall highly hydrophobic and hard for drugs to cross.

Pathogenic mycobacteria carry mycolic acid subtypes containing cyclopropane rings. The authors show that thiacetazone inhibits the cyclopropanation of these cell wall mycolic acids. Weakening the wall's chemistry explains the drug's effect and suggests related targets for new TB drugs.

Catalog record

CREATORAnuradha Alahari, Xavier Trivelli, Yann Guérardel et al.
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001343

Browse the full library · About the Tower of Babel